Pricing Log in Create free account

Acumen Pharmaceuticals, Inc. (ABOS) vs Anavex Life Sciences Corp. (AVXL)

Acumen Pharmaceuticals, Inc. and Anavex Life Sciences Corp. are both Biotechnology companies. Anavex Life Sciences Corp. is the larger, with a market value of $137.2M against $120.8M — 1.1× the size. Across the 9 metrics below, Anavex Life Sciences Corp. leads on 8 and Acumen Pharmaceuticals, Inc. on 1.

Valuation

Metric ABOS AVXL Biotechnology median
P/E n/m n/m 8.42
P/S 84.02 n/m 10.01
P/B 2.11 1.22 2.21
Price to free cash flow n/m n/m 21.01
EV/EBITDA n/m n/m 0.61
EV/Sales 29.27 n/m 9.41
Earnings yield (97.60%) (10.14%) (31.85%)
Free cash flow yield (76.15%) (21.35%) (24.58%)

Profitability

Metric ABOS AVXL Biotechnology median
Gross margin 0.00% — 65.16%
Operating margin 0.00% 0.00% 0.00%
Net margin 0.00% 0.00% 0.00%
Free cash flow margin 0.00% 0.00% 0.00%
Return on equity (120.50%) (12.80%) (56.36%)
Return on assets (72.97%) (11.70%) (48.04%)
Return on invested capital 0.00% 0.00% 0.00%

Growth

Metric ABOS AVXL Biotechnology median
Revenue growth (TTM) — — 6.02%
EPS growth (last fiscal year) (16.96%) (3.85%) 30.26%
Revenue growth, 5-year CAGR — — 9.41%
Net income growth, 5-year CAGR 0.00% 0.00% 0.00%

Health

Metric ABOS AVXL Biotechnology median
Debt to equity 0.55 0.00 0.00
Current ratio 2.47 15.62 4.72
Net debt to EBITDA 0.69 2.00 0.96

Dividend

Metric ABOS AVXL Biotechnology median
Dividend yield — — 0.08%
Payout ratio — — —

Size

Metric ABOS AVXL Biotechnology median
Market cap 120.77m 137.19m 132.35m

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack